Details of the Drug Therapeutic Target (DTT)

General Information of Drug Therapeutic Target (DTT) (ID: TTC6JZQ)

DTT Name	Haemophilus influenzae CRM197 (Hae-influ CRM197)
Gene Name	Hae-influ CRM197
DTT Type	Clinical trial target	[1]
UniProt ID	NOUNIPROTAC
TTD ID	T96257

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This DTT

2 Clinical Trial Drug(s) Targeting This DTT

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
HibTITER	DMO10JI	Pneumococcal infection	CA00-CA40	Phase 2	[2]
NU300	DMO0C5R	Influenza virus infection	1E30-1E32	Phase 2	[1]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT02140047) Exploratory Clinical Study of MT-2301. U.S. National Institutes of Health.
2	Immunogenicity and safety of Haemophilus influenzae type b conjugate vaccine (HibTITER) and a combination vaccine of diphtheria, tetanus, pertussis and HibTITER (TETRAMUNE) in two-month-old infants. J Microbiol Immunol Infect. 1998 Sep;31(3):180-6.